Safoora Naveed, Asher Ahmed Mashhood, Sakina Sadiq Malik, Abrar Ahmad Khalid, Muhammad Anjum, Ayesha Ellahi, Zafar Iqbal Shaikh.
Comparative study of efficacy of topical anthralin (0.5%) and topical calcipotriol (0.005%) in management of chronic plaque psoriasis.
J Pak Assoc Derma Jan ;33(3):827-31.

Objective: The aim of the study is to compare the efficacy of topical calcipotriol (0.005%) and topical anthralin (0.5%) in treatment of Chronic Plaque Psoriasis (CPP).   Methods: This randomized, interventional study was conducted at Pak Emirates Military Hospital, Rawalpindi and Combined Military Hospital, Rawalpindi for 6-month period (10th January 2020 to 10th July 2020). A sample of 186 patients was randomly distributed in two groups. In group A, patients applied topical anthralin (0.5%) every night for 12 weeks. In group B, patients applied topical calcipotriol (0.005%) every night for 12 weeks. The follow up period was 12 weeks and assessment of the efficacy was done at 4, 8 and 12 weeks by utilizing PASI score.   Results: The age range of the individuals was from 15 to 50 years. The average duration of presenting complaint for Group A was 8.903±1.85 months while for Group B was 9.193±2.58 months. In Group A, the average PASI score before and after the treatment was 16.22±3.02 and 4.784±3.28 respectively and in Group B the average PASI score before and after the treatment was 16.03±2.09 and 2.376±2.39 respectively. The number of male patients in each group was more than female. Efficacy i.e. reduction in PASI score by 75% was seen in 21.5% patients of Group A as compared to 43% in Group B (p=0.001).   Conclusion: In conclusion, 0.005% calcipotriol is considerably more efficacious than 0.5% anthraline in bringing disease improvement and patient satisfaction than 0.5% anthraline.  

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com